Japan’s Opposition Parties Submit Hepatitis Treatment Aid Bill
This article was originally published in PharmAsia News
Executive Summary
In a push for more hepatitis patients to seek treatment, four opposition parties in Japan - Japan Democratic Party, Communist Party, Social Democratic Party and People's New Party - jointly submitted a Hepatitis Medical Treatment Aid bill to the House of Representatives. Compared to the ruling Liberal Democratic Party's proposal, which only subsidizes interferon treatment, the new bill allows subsidization of both interferon treatments and combination treatments with antiviral drugs. It also lowers individual's monthly payment to zero, ¥10,000, or ¥20,000 based on individual income levels, compared to LDP's proposed payments of ¥10,000, ¥30,000 or ¥50,000 monthly payments. The average interferon treatment costs ¥80,000 per month. (Click here for more - Japanese language
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.